Researchers have been excited about the medication , a novel dual agonist showing significant outcomes in early trials for weight reduction . It functions by impacting two hormones : GLP-1 and GIP, which https://emilyvgmv027509.sharebyblog.com/40662932/the-new-hope-for-weight-management